Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02250430 · ClinicalTrials.gov registry record · Phase 1
A Phase 1 Study Assessing Local Cutaneous Effects of SB204
A Phase 1 study, sponsored by Novan.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT02250430 is a Phase 1 study that has completed, run by Novan. The registered enrollment target is 8 participants.
The verdict
NCT02250430, a Phase 1 study, has completed, sponsored by Novan.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.
Interventions
- DRUG SB204
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-09 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02250430
The ClinicalTrials.gov registry entry for NCT02250430 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novan, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SB204 is the first listed.
NCT02250430 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02250430 about?
NCT02250430 is a clinical study titled "A Phase 1 Study Assessing Local Cutaneous Effects of SB204". In this study, color (erythema) and pH will be measured on 3 consecutive days after application of 2 doses of SB204 to the cheeks of healthy volunteers.
What is the current status of trial NCT02250430?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2014-09. Estimated completion is 2014-09.
What interventions are being tested in trial NCT02250430?
The interventions under investigation include: SB204 (DRUG).
Who is sponsoring clinical trial NCT02250430?
This trial is sponsored by Novan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.